Test Discontinuations // Hereditary Cancer Single Gene Panels

Dear Valued Clients,

Thank you for your continued trust in Baylor Genetics as your genetic testing partner. As we continually upgrade and refine our test menu and services, we want you to be the first to know about the changes that may affect your testing with us.

Effective May 27, 2020 in a continuing effort to optimize our offering, the following test codes will be discontinued:

Test Code Test Description
21405 CBL Gene Sequencing by Massively Parallel Sequencing 
21410 RIT1 Gene Sequencing by Massively Parallel Sequencing 
22305 ALK Gene Sequencing by Massively Parallel Sequencing 
22315 MRE11A Gene Sequencing by Massively Parallel Sequencing 
22345 SUFU Gene Sequencing by Massively Parallel Sequencing 
22440 RAD50 Gene Sequencing by Massively Parallel Sequencing 
22520 MET Gene Sequencing by Massively Parallel Sequencing 
22530 WT1 Gene Sequencing by Massively Parallel Sequencing 
22605 CDC73 Gene Sequencing by Massively Parallel Sequencing 
22610 PRKAR1A Gene Sequencing by Massively Parallel Sequencing 
22615 TMEM127 Gene Sequencing by Massively Parallel Sequencing 
22620 MAX Gene Sequencing by Massively Parallel Sequencing 
22730 CEBPA Gene Sequencing by Massively Parallel Sequencing 
22810 CDK4 Gene Sequencing by Massively Parallel Sequencing 
22815 CDKN2A Gene Sequencing by Massively Parallel Sequencing 

If you have specific questions regarding these updates, please contact your Baylor Genetics account representative, call our Client Relations Division at 1-800-411-4363, or email us at help@baylorgenetics.com. For additional oncology test offerings, please visit our Test Menu. 

Thank you for your continued business. 

Previous Post
Test Discontinuation // ClariFind
Next Post
Test Discontinuation // Overgrowth Panel
Menu